JD Health International Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Enlin Jin
Algemeen directeur
CN¥8.4m
Totale compensatie
| Percentage CEO-salaris | 15.0% |
| Dienstverband CEO | 3.2yrs |
| Eigendom CEO | 0.01% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 4yrs |
Recente managementupdates
Recent updates
Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04
Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?
Sep 26A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Sep 05Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence
Aug 08Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price
Jul 21This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends
Dec 07What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?
Nov 20JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 02Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital
Aug 21JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price
Aug 03JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues
Jun 08Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?
Apr 19Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
Dec 29Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?
Sep 14A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Dec 04Calculating The Fair Value Of JD Health International Inc. (HKG:6618)
Mar 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥3b |
| Mar 31 2024 | n/a | n/a | CN¥2b |
| Dec 31 2023 | CN¥8m | CN¥1m | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥1b |
| Dec 31 2022 | CN¥8m | CN¥1m | CN¥380m |
| Sep 30 2022 | n/a | n/a | -CN¥7m |
| Jun 30 2022 | n/a | n/a | -CN¥395m |
| Mar 31 2022 | n/a | n/a | -CN¥734m |
| Dec 31 2021 | CN¥3m | CN¥301k | -CN¥1b |
Compensatie versus markt: De totale vergoeding ($USD 1.16M ) Enlin } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 906.43K ).
Compensatie versus inkomsten: De vergoeding van Enlin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Enlin Jin (43 yo)
3.2yrs
Tenure
CN¥8,385,000
Compensatie
Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Executive Director | 3.2yrs | CN¥8.39m | 0.011% HK$ 9.2m | |
| Independent Non-Executive Director | 2.6yrs | CN¥818.00k | 0.00030% HK$ 254.6k | |
| Chairman | 4.2yrs | CN¥407.82m | 0.56% HK$ 471.4m | |
| Non-Executive Director | 4.3yrs | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 4yrs | CN¥476.00k | 0.00018% HK$ 152.8k | |
| Independent Non-Executive Director | 4yrs | CN¥476.00k | 0.00018% HK$ 152.8k | |
| Independent Non-Executive Director | 3.7yrs | CN¥463.00k | 0.00019% HK$ 161.2k |
4.0yrs
Gemiddelde duur
51yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 6618 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).